Introducing the third installment of our recently launched Complimentary Exclusive Video Interview. Jonathan Usuka, Chief Business Officer at Sapient, highlighted Sapient’s high throughput proteomics and metabolomics capabilities to generate multi-omics data and the analytical power to transcend the genome to achieve robust biological discoveries in expediting clinical studies.
By leveraging Sapient’s real-world data asset, the Human Biology Database, Jonathan manages commercial collaborations, strategic partnerships, and client service innovation across the company’s proteomic and metabolomic offerings.
Image Source: Canva
About the Author:
.png)
Jonathan Usuka
With a deep experience in business and scientific leadership in the pharmaceutical industry spanning more than 25 years, Jonathan joined Sapient from REALM IDx, where he led the creation and launch of integrated diagnostics in pharmaceutical services and pivoted the company to profitability, resulting in a successful exit to strategic and private equity investors. Previously, Dr. Usuka was a Senior Expert at McKinsey & Company, leading their Center for Analytics and Real-world Evidence. In that role he served pharmaceutical industry leaders in advancing their therapeutic pipelines through AI and supported M&A strategy for private equity investors in pharmaceutical services. He has also held senior roles at top pharmaceutical companies including as Director, R&D Informatics at Celgene and as Director, Global R&D Information at Roche. Dr. Usuka earned a PhD in Chemistry and was an NIH Fellow in Genetics at Stanford University’s School of Medicine, and holds an MBA in Finance from The Wharton School, University of Pennsylvania and a BA from Princeton University.
Related Post: Spotlight: Nick Kadysh the Founding CEO & President at PharmAla Biotech, in an Illuminating Dialogue Exchange with PharmaShots
